Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Conditions:   Pancreas Cancer;   Pancreatic Cancer;   Cancer of the Pancreas
Interventions:   Biological: Neoantigen Peptide Vaccine;   Drug: Poly ICLC;   Procedure: Blood for immune monitoring
Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 20, 2019 / by / in
Comments